China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IDYA Ideaya Biosciences, Inc.	$1.09B	$514,000 0.06% of portfolio	16,249	Q3 2024 Added 82.72%
PTGX Protagonist Therapeutics, Inc	$1.79B	$509,000 0.06% of portfolio	11,329	Q3 2024 Added 64.4%
VCYT Veracyte, Inc.	$2.9B	$502,000 0.06% of portfolio	14,773	Q3 2024 Added 64.46%
IBRX Immunity Bio, Inc.	$1.18B	$497,000 0.06% of portfolio	133,966	Q3 2024 Added 64.88%
ACAD Acadia Pharmaceuticals Inc	$2.84B	$490,000 0.05% of portfolio	31,903	Q3 2024 Added 64.36%
AGIO Agios Pharmaceuticals, Inc.	$1.78B	$486,000 0.05% of portfolio	10,942	Q3 2024 Added 64.05%
EWTX Edgewise Therapeutics, Inc.	$1.69B	$481,000 0.05% of portfolio	18,035	Q3 2024 Added 64.36%
VERA Vera Therapeutics, Inc.	$886M	$465,000 0.05% of portfolio	10,545	Q3 2024 Added 64.07%
ARWR Arrowhead Pharmaceuticals, Inc.	$2.07B	$462,000 0.05% of portfolio	23,910	Q3 2024 Added 63.86%
SWTX Spring Works Therapeutics, Inc.	$2.16B	$457,000 0.05% of portfolio	14,285	Q3 2024 Added 64.14%
JANX Janux Therapeutics, Inc.	$1.69B	$455,000 0.05% of portfolio	10,033	Q3 2024 Added 64.75%
HRMY Harmony Biosciences Holdings, Inc.	$2.31B	$436,000 0.05% of portfolio	10,931	Q3 2024 Added 63.83%
KROS Keros Therapeutics, Inc.	$280M	$419,000 0.05% of portfolio	7,217	Q3 2024 Added 70.25%
NTLA Intellia Therapeutics, Inc.	$722M	$401,000 0.04% of portfolio	19,537	Q3 2024 Added 72.39%
VCEL Vericel Corp	$2.79B	$398,000 0.04% of portfolio	9,430	Q3 2024 Added 65.18%
BEAM Beam Therapeutics Inc.	$1.65B	$394,000 0.04% of portfolio	16,087	Q3 2024 Added 62.4%
NVAX Novavax Inc	$657M	$388,000 0.04% of portfolio	30,791	Q3 2024 Added 86.67%
AKRO Akero Therapeutics, Inc.	$1.11B	$383,000 0.04% of portfolio	13,354	Q3 2024 Added 64.38%
MIRM Mirum Pharmaceuticals, Inc.	$1.73B	$357,000 0.04% of portfolio	9,176	Q3 2024 Added 65.72%
LGND Ligand Pharmaceuticals Inc	$1.89B	$351,000 0.04% of portfolio	3,514	Q3 2024 Added 66.38%
RXRX Recursion Pharmaceuticals, Inc.	$1.18B	$348,000 0.04% of portfolio	52,905	Q3 2024 Added 95.55%
MNKD Mannkind Corp	$1.55B	$332,000 0.04% of portfolio	52,890	Q3 2024 Added 65.31%
ARVN Arvinas, Inc.	$960M	$325,000 0.04% of portfolio	13,203	Q3 2024 Added 64.22%
RCKT Rocket Pharmaceuticals, Inc.	$780M	$323,000 0.04% of portfolio	17,505	Q3 2024 Added 64.12%
SNDX Syndax Pharmaceuticals Inc	$740M	$315,000 0.04% of portfolio	16,367	Q3 2024 Added 63.93%
ARDX Ardelyx, Inc.	$787M	$311,000 0.03% of portfolio	45,280	Q3 2024 Added 64.73%
BCRX Biocryst Pharmaceuticals Inc	$1.39B	$302,000 0.03% of portfolio	39,791	Q3 2024 Added 64.11%
KURA Kura Oncology, Inc.	$486M	$288,000 0.03% of portfolio	14,739	Q3 2024 Added 64.66%
NRIX Nurix Therapeutics, Inc.	$919M	$278,000 0.03% of portfolio	12,388	Q3 2024 Added 77.76%
DAWN Day One Biopharmaceuticals, Inc.	$921M	$267,000 0.03% of portfolio	19,203	Q3 2024 Added 87.02%
OCUL Ocular Therapeutix, Inc	$620M	$260,000 0.03% of portfolio	29,989	Q3 2024 Added 64.81%
TARS Tarsus Pharmaceuticals, Inc.	$1.25B	$240,000 0.03% of portfolio	7,317	Q3 2024 Added 64.87%
XNCR Xencor Inc	$1.15B	$239,000 0.03% of portfolio	11,893	Q3 2024 Added 64.2%
PHAT Phathom Pharmaceuticals, Inc.	$273M	$237,000 0.03% of portfolio	13,134	Q3 2024 Added 90.98%
INVA Innoviva, Inc.	$1.3B	$232,000 0.03% of portfolio	12,033	Q3 2024 Added 64.05%
IMCR Immunocore Holdings PLC	$1.27B	$231,000 0.03% of portfolio	7,433	Q3 2024 Added 69.7%
ZLAB Zai Lab LTD	$2.55B	$230,000 0.03% of portfolio	9,559	Q3 2024 Added 58.13%
COGT Cogent Biosciences, Inc.	$535M	$227,000 0.03% of portfolio	21,051	Q3 2024 Added 87.42%
MRVI Maravai Lifesciences Holdings, Inc.	$627M	$226,000 0.03% of portfolio	27,225	Q3 2024 Added 74.47%
CNTA Centessa Pharmaceuticals PLC	$1.4B	$217,000 0.02% of portfolio	13,593	Q3 2024 Added 99.66%
ARQT Arcutis Biotherapeutics, Inc.	$763M	$209,000 0.02% of portfolio	22,482	Q3 2024 Added 65.3%
TVTX Travere Therapeutics, Inc.	$1.18B	$205,000 0.02% of portfolio	14,712	Q3 2024 Added 64.47%
AUPH Aurinia Pharmaceuticals Inc.	$1.14B	$201,000 0.02% of portfolio	27,502	Q3 2024 Added 63.68%
GMAB Genmab A/S	$13.7B	$196,000 0.02% of portfolio	8,064	Q3 2024 Added 63.67%
WVE Wave Life Sciences Ltd.	$978M	$196,000 0.02% of portfolio	23,991	Q3 2024 Added 66.74%
VIR Vir Biotechnology, Inc.	$1.34B	$196,000 0.02% of portfolio	26,280	Q3 2024 Added 64.39%
CGEM Cullinan Oncology, Inc.	$463M	$186,000 0.02% of portfolio	11,151	Q3 2024 Added 64.69%
RLAY Relay Therapeutics, Inc.	$536M	$182,000 0.02% of portfolio	25,751	Q3 2024 Added 65.13%
SANA Sana Biotechnology, Inc.	$601M	$177,000 0.02% of portfolio	42,787	Q3 2024 Added 64.42%
PRTA Prothena Corp Public LTD CO	$646M	$173,000 0.02% of portfolio	10,344	Q3 2024 Added 63.72%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.